Genome & Company (CEO Bae Ji-soo and Park Han-soo), a leading global cancer immunotherapy company, will hold the 40th Annual JP Morgan Healthcare Conference Virtual, which will be held in San Francisco, USA for three days from January 10 to 13, 2022. We are officially invited to participate in the JPM Conference (hereinafter referred to as the JPM Conference) and hold 1:1 partnering meetings with global pharmaceutical companies.
Genome & Company has actively utilized the JP Morgan conference to achieve business development results, including participating for five consecutive years since its founding in 2018. Through the JPM Conference, Genome & Company signed a joint research and development agreement (CTCSA) for GEN-001 with Merck and Pfizer of Germany in 2019, and a second joint research and development agreement with Merck and Pfizer of Germany on gastric adenocarcinoma and gastroesophageal junction cancer in 2021. A contract (CTCSA) was signed. This year, we are conducting final coordination of additional joint research and development of ‘GEN-001’ with multinational pharmaceutical companies through 1:1 partnering meetings, and discussing commercialization of ‘GENA-104’, a new target immunotherapy drug in the main pipeline. do.
Genome & Company’s antibody pipeline is different in that it discovers novel targets and develops new antibody drugs that inhibit them through GNOCLE™, the company’s independent drug candidate discovery technology platform. In the case of ‘GENA-104’, the representative pipeline, the efficacy of effectively killing cancer cells by activating immune cells (T cells) was confirmed through preclinical research. In the case of ‘GEN-001’, an immunotherapy microbiome treatment, a clinical trial is being conducted in combination with Bavencio® from Merck and Pfizer in Germany.
Bae Ji-su, CEO of Genome & Company, said, “A number of global pharmaceutical companies are showing interest in the company’s major pipelines,” adding, “As in-depth discussions are taking place centered on the company’s major pipelines, the past BIO EU and BIO US “We will make sure that the results of the matters discussed are made public as soon as possible,” he said.
Meanwhile, the JP Morgan Healthcare Conference, which started in 1983, is the world’s largest healthcare investment conference in which pharmaceutical companies and medical service companies from around the world participate. Various meetings are held for global healthcare companies, including introduction of the company’s pipeline, research cooperation, and investment attraction.
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Valley 2021’ news